You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Columbus, Ohio 43205

  • Kidney Transplantation


The purpose of this study is to evaluate the safety and tolerability of RAD001 (Certican) administered to pediatric renal transplant recipients, and to provide additional safety data.


Inclusion Criteria: - Male and female patients no more than 16 years of age. - Patients receiving a primary cadaveric or non-HLA identical living donor (related or unrelated) renal transplant. - The graft must be functional within 48 hours post transplantation. Exclusion Criteria: - Cold ischemia time greater than 40 hours. - Patients who are recipients of multiple solid organ transplants, including dual and en bloc kidneys, or who have previously received transplanted organs. - Patients with panel reactive T cell antibodies of 50 % or higher at the last assessment before transplantation.



Primary Contact:

Study Director

Backup Contact:


Location Contact:

Columbus, Ohio 43205
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.